Group 1 - The core issue is that Shanghai Pharmaceuticals (Jinzhou) Co., Ltd. has been listed on the military procurement dishonesty list due to violations of "collusion in bidding" [1] - The company is prohibited from participating in military material engineering service procurement activities for three years, effective from December 15, 2025 [2] - The company primarily engages in the distribution and marketing of pharmaceuticals and medical devices, with an annual sales revenue of approximately 90 million yuan [4] Group 2 - Shanghai Pharmaceuticals (Jinzhou) Co., Ltd. was established in 2006 with a registered capital of 10 million yuan, and its major shareholder is Liaoning Province Pharmaceutical Foreign Trade Co., Ltd. [4] - The legal representative of the company was changed from Yuan Kehua to Jiang Ze on July 7 [4]

Group 1 - Jiangsu Equipment Complete Co., Ltd. has been listed in the military procurement dishonesty list due to violations such as refusing to sign contracts without justifiable reasons after winning a bid [1] - The company will be permanently banned from participating in military procurement activities related to cyberspace engineering services starting from September 7, 2025 [2] - The legal representative, Huang Xu, and other companies he controls or manages are also prohibited from participating in military procurement activities during the ban period [2] Group 2 - Jiangsu Equipment Complete Co., Ltd. was established in 2003 as a state-owned enterprise under the Jiangsu Provincial State-owned Assets Supervision and Administration Commission [2] - The company provides complete equipment and technical consulting services for key national construction projects and underwent a restructuring in 2008 [2] - In May 2020, Jiangsu Equipment Complete Co., Ltd. transitioned to a joint-stock company and was listed on the National Equities Exchange and Quotations system in February 2023 with the stock code 873847 [2]